Revvity, Inc. (RVTY) Stock
RVTY Key Statistics
About Revvity, Inc.
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.
CEO: Prahlad R. Singh. Company website
RVTY — Frequently Asked Questions
What is the RVTY stock price today?
Revvity, Inc. (RVTY) trades at $143.45, down 2.24% on the day, as of Sep 20, 2026 14:59 UTC.
What is Revvity, Inc.'s market cap?
Revvity, Inc. has a market capitalisation of $16.00B, calculated from the live RVTY share price and shares outstanding.
What is the P/E ratio of RVTY?
RVTY trades at a trailing P/E of 68.31, from earnings per share of $2.10 over the last twelve months.
How much revenue does Revvity, Inc. make?
Revvity, Inc. generated revenue of $2.91B over the trailing twelve months, which puts the stock at 5.50 times sales.
What is the 52-week range for RVTY?
RVTY has traded between $81.22 and $149.52 over the past 52 weeks, and the last price is 4.1% below that high.
Is Revvity, Inc. profitable?
Yes. Revvity, Inc. keeps 8.16% of revenue as net income over the trailing twelve months.
What is the analyst price target for RVTY?
Wall Street analysts rate RVTY Buy, with an average price target of $124.00, 13.6% below the current price.
What sector is Revvity, Inc. in?
Revvity, Inc. is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.
Who is the CEO of Revvity, Inc.?
Prahlad R. Singh is the chief executive of Revvity, Inc., which employs 11,000 people.
Where can I track RVTY in real time?
QFI Terminal shows RVTY with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See RVTY live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open RVTY in Terminal See plans